Male Hypogonadism - Epidemiology Forecast to 2027

Male Hypogonadism - Epidemiology Forecast to 2027

Category

Pharmaceuticals

Published Date

1st Feb 2018

Pages

50

Choose License

Final Price

DelveInsight's "Male Hypogonadism - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Male Hypogonadism epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2027

Male Hypogonadism Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Male Hypogonadism in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Male Hypogonadism outlook. It also includes the explanation of changing trends of epidemiology outlining the Male Hypogonadism scenario.

Male Hypogonadism Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Male Hypogonadism thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Male Hypogonadism explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Male Hypogonadism Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Male Hypogonadism

Key assessments
• Patient Segmentation in Male Hypogonadism
• Male Hypogonadism Risk & Burden
• Factors driving growth in a specific Male Hypogonadism patient population
1. Report Introduction
2. Male Hypogonadism Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Male Hypogonadism in 2017
2.2. Patient Share Distribution of Male Hypogonadism in 2027
3. Disease Background and Overview: Male Hypogonadism
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Male Hypogonadism in 7MM
4.3. Total Prevalent/ Incident Patient Population of Male Hypogonadism in 7MM – By Countries
5. Epidemiology of Male Hypogonadism by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Male Hypogonadism
5.1.3. Sub-Type Specific cases of the Male Hypogonadism *
5.1.4. Sex- Specific Cases of the Male Hypogonadism *
5.1.5. Diagnosed Cases of the Male Hypogonadism
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Male Hypogonadism
5.4.3. Sub-Type Specific cases of the Male Hypogonadism *
5.4.4. Sex- Specific Cases of the Male Hypogonadism *
5.4.5. Diagnosed Cases of the Male Hypogonadism
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Male Hypogonadism
5.5.3. Sub-Type Specific cases of the Male Hypogonadism *
5.5.4. Sex- Specific Cases of the Male Hypogonadism *
5.5.5. Diagnosed Cases of the Male Hypogonadism
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Male Hypogonadism
5.6.3. Sub-Type Specific cases of the Male Hypogonadism *
5.6.4. Sex- Specific Cases of the Male Hypogonadism *
5.6.5. Diagnosed Cases of the Male Hypogonadism
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Male Hypogonadism
5.7.3. Sub-Type Specific cases of the Male Hypogonadism *
5.7.4. Sex- Specific Cases of the Male Hypogonadism *
5.7.5. Diagnosed Cases of the Male Hypogonadism
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Male Hypogonadism
5.8.3. Sub-Type Specific cases of the Male Hypogonadism *
5.8.4. Sex- Specific Cases of the Male Hypogonadism *
5.8.5. Diagnosed Cases of the Male Hypogonadism
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Male Hypogonadism
5.9.3. Sub-Type Specific cases of the Male Hypogonadism *
5.9.4. Sex- Specific Cases of the Male Hypogonadism *
5.9.5. Diagnosed Cases of the Male Hypogonadism
6. Unmet Needs of the Male Hypogonadism
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific
Table 1: Total Prevalent/Incident Cases of the Male Hypogonadism in 7MM
Table 2: Total Prevalent/Incident Cases of the Male Hypogonadism in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Male Hypogonadism in United States (2016-2027)
Table 4: Sub-Type Specific cases of the Male Hypogonadism in United States (2016-2027)*
Table 5: Sex- Specific Cases of the Male Hypogonadism in United States (2016-2027)*
Table 6: Diagnosed Cases of the Male Hypogonadism in United States (2016-2027)
Table 7: Prevalent/Incident Cases of the Male Hypogonadism in Germany (2016-2027)
Table 8: Sub-Type Specific cases of the Male Hypogonadism in Germany (2016-2027) *
Table 9: Sex- Specific Cases of the Male Hypogonadism in Germany (2016-2027) *
Table 10: Diagnosed Cases of the Male Hypogonadism in Germany (2016-2027)
Table 11: Prevalent/Incident Cases of the Male Hypogonadism in France (2016-2027)
Table 12: Sub-Type Specific cases of the Male Hypogonadism in France (2016-2027) *
Table 13: Sex- Specific Cases of the Male Hypogonadism in France (2016-2027) *
Table 14: Diagnosed Cases of the Male Hypogonadism in France (2016-2027)
Table 15: Prevalent/Incident Cases of the Male Hypogonadism in Italy (2016-2027)
Table 16: Sub-Type Specific cases of the Male Hypogonadism in Italy (2016-2027) *
Table 17: Sex- Specific Cases of the Male Hypogonadism in Italy (2016-2027) *
Table 18: Diagnosed Cases of the Male Hypogonadism in Italy (2016-2027)
Table 19: Prevalent/Incident Cases of the Male Hypogonadism in Spain (2016-2027)
Table 20: Sub-Type Specific cases of the Male Hypogonadism in Spain (2016-2027) *
Table 21: Sex- Specific Cases of the Male Hypogonadism in Spain (2016-2027) *
Table 22: Diagnosed Cases of the Male Hypogonadism in Spain (2016-2027)
Table 23: Prevalent/Incident Cases of the Male Hypogonadism in UK (2016-2027)
Table 24: Sub-Type Specific cases of the Male Hypogonadism in UK (2016-2027) *
Table 25: Sex- Specific Cases of the Male Hypogonadism in UK (2016-2027) *
Table 26: Diagnosed Cases of the Male Hypogonadism in UK (2016-2027)
Table 27: Prevalent/Incident Cases of the Male Hypogonadism in Japan (2016-2027)
Table 28: Sub-Type Specific cases of the Male Hypogonadism in Japan (2016-2027) *
Table 29: Sex- Specific Cases of the Male Hypogonadism in Japan (2016-2027) *
Table 30: Diagnosed Cases of the Male Hypogonadism in Japan (2016-2027)

Get Free Sample

You can get a FREE sample of any report. Just click the "Free Sample" link.

Explore Latest Reports

If you have any special requirement or looking for more discounts, Kindly contact our sales team

Contact Us